Program developed by Medavera, Inc. will take place during IDWeek 2024 LOS ANGELES, Oct. 5, 2024 /PRNewswire/ — With infectious diseases ranking as the third leading cause of death globally and the growing health threat of antimicrobial resistance, multiplex molecular assays are emerging…
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.